Compounds > n-((2-dimethylamino)ethyl)-9-aminoacridine-4-carboxamide
Page last updated: 2024-09-03

n-((2-dimethylamino)ethyl)-9-aminoacridine-4-carboxamide and Adenocarcinoma, Basal Cell

n-((2-dimethylamino)ethyl)-9-aminoacridine-4-carboxamide has been researched along with Adenocarcinoma, Basal Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atwell, GJ; Baguley, BC; Cain, BF; Denny, WA; Finlay, GJ1

Other Studies

1 other study(ies) available for n-((2-dimethylamino)ethyl)-9-aminoacridine-4-carboxamide and Adenocarcinoma, Basal Cell

ArticleYear
Potential antitumor agents. 43. Synthesis and biological activity of dibasic 9-aminoacridine-4-carboxamides, a new class of antitumor agent.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:11

    Topics: Adenocarcinoma; Aminoacridines; Animals; Antineoplastic Agents; Cell Line; DNA; Humans; Leukemia L1210; Leukemia P388; Male; Mice; Mice, Inbred DBA

1984